Bridges Investment Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4.29M Buy
44,339
+175
+0.4% +$16.5K 2.37% 8
2017
Q3
$3.92M Sell
44,164
-30,997
-41% -$2.36M 2.18% 11
2017
Q2
$5.45M Buy
75,161
+41,205
+121% +$2.77M 1.24% 28
2017
Q1
$2.21M Sell
33,956
-42,570
-56% -$2.68M 0.65% 41
2016
Q4
$4.79M Sell
76,526
-1,264
-2% -$77.2K 1.17% 31
2016
Q3
$4.91M Buy
77,790
+1,300
+2% +$84.2K 1.03% 31
2016
Q2
$4.74M Buy
76,490
+2,875
+4% +$175K 1.04% 28
2016
Q1
$4.21M Buy
73,615
+38,485
+110% +$2.15M 0.91% 35
2015
Q4
$2.36M Hold
35,130
0.41% 58
2015
Q3
$2.36M Sell
35,130
-32,652
-48% -$2.13M 0.41% 58
2015
Q2
$4.55M Sell
67,782
-1,260
-2% -$82.3K 1.07% 32
2015
Q1
$4.04M Buy
69,042
+2,091
+3% +$126K 0.92% 38
2014
Q4
$4.38M Sell
66,951
-86
-0.1% -$5.42K 1% 35
2014
Q3
$3.87M Hold
67,037
0.89% 37
2014
Q2
$3.78M Buy
67,037
+1,025
+2% +$53.8K 0.87% 41
2014
Q1
$3.39M Sell
66,012
-2,347
-3% -$119K 0.79% 44
2013
Q4
$3.61M Buy
68,359
+213
+0.3% +$10.5K 0.83% 41
2013
Q3
$3.05M Sell
68,146
-38
-0.1% -$1.68K 0.76% 44
2013
Q2
$2.82M Buy
+68,184
New +$2.98M 0.72% 47

Other funds holding ABBV

Bridges Investment Counsel's ABBV Position: Q4 2017 in Review

Bridges Investment Counsel increased its AbbVie (ABBV) stake by 0.4% in Q4 2017, buying an estimated $16.5K and bringing the position to 44,339 shares worth $4.29M. The position accounts for 2.37% of the portfolio, ranked #8.

Bridges Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $5.45M in Q2 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Bridges Investment Counsel held 44,339 shares of AbbVie worth $4.29M as of Q4 2017.
  • Bridges Investment Counsel bought 175 AbbVie shares in Q4 2017, an estimated $16.5K.
  • AbbVie made up 2.37% of Bridges Investment Counsel's portfolio in Q4 2017, its #8 holding.
  • Bridges Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's AbbVie position peaked at $5.45M in Q2 2017.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.